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NINDS funds stroke research center
As program director and principal investigator, Colin
Derdeyn, MD, professor of radiology, of neurology, and of neurological surgery, received a $9.3 million grant from the National
Institute of Neurological Disorders and Stroke (NINDS)—a
part of the National Institutes of Health (NIH)—to develop new
methods for diagnosing and treating stroke. Provisions of the
five-year grant allow for establishing a Specialized Program for
Translational Research in Acute Stroke (SPOTRIAS) Center at
Washington University Medical Center. The Medical Center's
efficient, high-volume acute stroke treatment team and
Mallinckrodt Institute's reputation as a leader in radiology were
recognized as major strengths of their successful application.
Co-investigators for the Washington University SPOTRIAS
Center are from the following groups:
• Department of Emergency Medicine—Larry Lewis, MD; David
Tan, MD; Douglas Char, MD
• Department of Neurology—Abdullah Nassief, MD; Jin-Moo Lee,
MD, PhD; David Carpenter, MD; Allyson Zazulia, MD; Michael
Diringer, MD; Mark Goldberg, MD
• Department of Neurosurgery—Gregory Zipfel, MD; Ralph
Dacey, MD; Robert Grubb, MD
• Department of Pathology—Mark Watson, MD, PhD
• Department of Radiology—Katie Vo, MD; Tom Videen, PhD
• Division of Biostatistics—Philip Miller, PhD; Gina D'Angelo,
PhD; Paul Thompson, PhD
• Occupational Therapy Pr
gram—Lisa Connor, PhD
• University of North Carolina—
William Powers, MD; Weili Lin, PhD.
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In addition to Washington
University in St. Louis, the following
institutions comprise the SPOTRIAS
research center network: Columbia
University; Harvard University;
University of California, Los Angeles; University of California, San
Diego; University of Cincinnati;
University of Texas, Houston; and
an NIH stroke treatment program
in Washington, DC.

SNM award
named for
Welch
In June at the 55th
Annual Meeting of the
Society of Nuclear
Medicine (SNM), the
Radiopharmaceutical
Sciences Council
announced the
creation of the
M
Michael J. Welch
Award, which will be
given annually for
significant contribuWelch (left) received a plaque commemorating the
tions to the field of
creation of the Welch Award from Robert Mach, PhD, I
radiopharmaceutical
president of the Radiopharmaceutical Sciences Council.;
sciences. The first
recipient will be announced at the 2009 SNM meeting.
The award's namesake is a pioneer in the field of radiopharmaceutical chemistry who specializes in the synthesis
of new radioactive chemicals for medical imaging. Welch,
professor of radiology, of chemistry, and of molecular biology
and pharmacology, joined the Mallinckrodt Institute faculty
in 1967 and was a member of the team that developed
positron emission tomography in the early 1970s.

Of note
Carolyn Anderson, PhD, professor of radiology, of biochemistry, and of chemistry, was elected vice president of the Society
of Nuclear Medicine's Molecular Imaging Center (MICoE) of
Excellence. She will assume the MICoE presidency in 2010.
Colin Derdeyn, MD, professor of radiology, of neurology, and of
neurological surgery, was elected president-elect of the Society >f
Nevtrolnterventional Surgery. He will be appointed president of
the Society in 2010.
Bennett Greenspan, MD, instructor in radiology, was elected to
two-year term as president of the Society of Nuclear Medicine's
Academic Council.

In July of 2008, a Siemens Biograph 40 TruePoint™ PET (positron emission tomography)CT (computed tomography) scanner was installed in the nuclear medicine area on the
Barnes-Jewish Hospital north campus. The new scanner, an addition to the Siemens
Biograph 2 already in place, offers faster scanning (20 slices per second), higher resolution images, and the capability for newer services such as cardiac PET—which translates
to more PET capacity and easier scheduling. Also installed in July was a Siemens Symbia
TruePoint SPECT-CT scanner; the addition of computed tomography to a nuclear medicine
camera aids in visualizing the body's anatomy.

Marcus Kessler, MD, nuclear me
cine chief resident, was appointt
to a one-year term on the Magne
Resonance Committee and the
Diagnostics Committee of the So
ety of Pediatric Radiology.
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Your teenage
son complains of
pain in one leg, that ifs
keeping him up at night.
Growing pains, you think, and tell him
the pain will go away. Not necessarily.
What he may be experiencing is an osteoid
osteoma, a noncancerous bone-forming tumor
that occurs most often in the long bone's of the lower
extremities. The femur, or thighbone, is the most common
location, although the tumor can occur in almost any bone—
especially the bones of the hand and sometimes the lower spine.
Regardless of the location, these tumors can be very painful.

RADIOFREQUENCY ABLATION:
forgeting Pain' UbltJUlU UbltJUIIIUi

Osteoid osteomas occur
when certain cells divide
uncontrollably, forming
a small, brownish-red,
gritty mass partially
comprised of bone. The
growing tumor displaces
healthy bone tissue with
its abnormal, hard tissue. These
growths generally emerge during
the teenage years or early adulthood
(ages 5 through 25), are found more
often in males than in females (2:1
ratio), and account for approximately
10 percent of all benign tumors.
The good news is the tumors typically do not progress in size beyond
a half inch in diameter, do not
harm the bone, and do not become
malignant. However, pain caused
by the tumor can rob patients of
sleep and comfort.

"Osteoid tumors are found in
many parts of the bone: the outer
portion, near the surface under the
periosteum fibrous coating; even in
the medullary cavity inside the
bone shaft where marrow is
stored," says Louis Gilula, MD, a
musculoskeletal interventional
radiologist at Mallinckrodt Institute.
"The lesion itself is an inflammatory
mixture created by the pressure
of the tumor and the chemicals
it forms."
SYMPTOMS
Depending on its location,
the osteoma can have different
symptoms:
Dull or sharp pain that worsens
at night
Pain usually relieved by aspirin
or other anti-inflammatory drugs
Limping
Painful scoliosis or muscle
spasms, and other nerve
symptoms like sciatica
(when the tumor is in
the spine)
Muscle atrophy from not
using the limb to avoid pain.
Gilula says that typically
these osteoid osteomas
occur as one tumor unilaterally, a characteristic that
distinguishes them from the
growing pains of youth,
which tend to be bilateral.

"Typically, they occur in one spot
and rarely recur," he says. "The
tumors might—but rarely—go
away, within 36 months on average,
without any treatment. However,
because of the associated pain,
patients generally don't want to
wait. No one knows why these
growths develop. Generally the
bone is not damaged, unless the
tumors occur on or near a growth
plate, which could cause bone
deformity because of the mass.
The decision to treat, in most
cases, is based on the patient's
level of pain."
DIAGNOSIS
Diagnosis may be made by
using one—or a combination—
of the following tests:
Xrays
• Computed tomography
Magnetic resonance imaging
Fluoroscopy
Bone scan
Complete blood count
Blood test.
Initial diagnosis is usually
made by X ray, which can detect
the bony growth of the tumor. "We
want to locate the radiolucent nidus,
or center of the osteoma," says
Gilula. "The growth is usually a
round shape, but it may be oblong,
conforming to some bony structure.
Once the diagnosis is made, the
condition can be treated."

23-YEAR-OLD WOMAN WITH AN
OSTEOID OSTEOMA
Left, top: Arrow points to central lucent nidus
(dark area) inside the femur.
Left, bottom: Biopsy needle shown just
above the nidus (arrow) prior to radiofrequency ablation treatment.
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ouis Gilula, MD,
in a sixth-floor
reading room in
the Center for
Advanced Medicine.

PERCUTANEOUS RF ABLATION
Traditionally, an osteoid
osteoma was surgically removed
by an orthopaedic surgeon. But
musculoskeletal interventional
radiologists—like Gilula and Daniel
Wessell, MD, PhD, instructor in
radiology in Mallinckrodt Institute's Musculoskeletal Radiology
section—are using a minimally
invasive procedure called percutaneous radiofrequency (RF) ablation.
Gilula, a professor of radiology,
of orthopaedic surgery, and of
plastic and reconstructive surgery,
has been using percutaneous RF
ablation to treat these noncancerous
tumors since 1997 and receives
patient referrals from a wide
geographic area.
While the patient is under
general anesthesia or deep conscious
sedation, the radiologist uses fluoroscopy or computed tomography
to locate the nidus. Then a small
hole is made into the nidus so the
tumor can be biopsied. Next, a
radiofrequency is sent through a
needle that is inserted into the center of the lesion. The radiofrequency generates heat —which is
increased to 90 degrees Centigrade—
that kills the tumor cells.

After allowing time for
recovery from the anesthesia,
most patients go home the same
day. The pain is usually gone by
the day following the RF ablation,
and regular activities can be
resumed. After the procedure, the
nidus gradually fills in the bone,
which usually is thickened around
the lesion and is even stronger than
normal; stress on the bone is not an
issue. The exception, says Gilula,
is for triathletes whose combination of activities puts undue stress
on their joints. For these patients,
Gilula recommends no training
for six weeks. HI

TREATMENT ALTERNATIVES
raping the tumor from the bone, using
nstrument called a curette. Donor bone tissue or
other materials are used to pack the cavity resulting from
the curettaqe.
1

En bloc resection:

gressive resection of the tumor,
I removal of a block of bone

... tumor and allowing for wide margins of
healthy tissue. This approach is typically unnecessary in
osteoid osteomas but was the treatment of choice prior
to RF ablation. More often, when pain interferes

Editor's Note: Physicians who have questions about
percutaneous RF ablation or want to refer a patient
may call (314)362-2825.

with daily activity, RF ablation of the tumor is the
treatment of choice.
1

Internal fixatioi

. .(lowing en bloc excision of the

Daniel Wessell,

ds or pins are used to support

MD, PhD, in the
fluoroscopy room

the bone.

on Mallinckrodt
Institute's third floor.

1

Surgery:

iuses, surgery may be the best

i iur lesions close to the spinal cord or in
. ry small bones close to the skin of the
wrist bones.
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by Amy Thomas, MD, FAAP

In a workday packed from start to finish with clinical duties, academic radiologists have limited time for medical research. Though
many have the vision necessary to improve the future of health and
medicine, the process of running a clinical research study can be a
daunting task. Even the most industrious physician is challenged to
find study participants, coordinate detailed research protocols,
monitor patients, and engage in all of the additional tasks required
to conduct a valid clinical trial.

But at Washington University
in St. Louis, one of the
world's largest academic
research centers, physicians conducting clinical
investigations that involve imaging
can turn to a team skilled in the
technical aspects of designing and
executing a successful research
protocol. Mallinckrodt Institute of
Radiology's Clinical Research
Laboratory (CRL) is a full-service
project coordination group whose
mission is to assist in any step of
the research process.
Led by Jeffrey Brown, MD;
Shelly Meese; and Robin Haverman, the CRL has grown since 1997
from a small group of five to what
is now a staff of 21 research specialists readily available to assist
clinicians with imaging research.
The CRL provides many services
that are essential to running a clinical
research trial such as participant
recruitment, obtaining patients'
vital signs, laboratory tests and
ECGs, image transfer and data
entry. The CRL also helps principal
investigators to identify appropriate
funding opportunities for a project,
prepare grant proposals, and prepare
Institutional Review Board (IRB)
applications. Research physicians
are often pressed to find time for

Jeffrey Brown, WD
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these duties, and guidance from
highly qualified and experienced
members of the CRL ensures that
these processes run smoothly,
without interrupting doctors' busy
clinical schedules and giving them
more time to focus on the scientific
aspects of research.
Getting projects off the ground
At the earliest stages of
research, the CRL plays a critical
role in development by finding
financial sponsors and submitting
grant proposals. Shelly Meese, MHA,
CRA, assistant director of the CRL,
is well-versed in locating potential
funding opportunities for imaging
research. Combining a scientific
background with a thorough knowledge of how and where to obtain
funding dollars, Meese is dedicated
to making the best match between
a clinician and a research sponsor.
The CRL staff also finds suitable
principal investigators when
approached by industry or agencies
such as the National Institutes of
Health. Once the match is made,
members of the CRL are committed

Ruth Holdener, RT(R), prepares (or a patient's computed tomography
scan in the Center (or Clinical Imaging Research.

Ready for the Institutional
Review Board
Before a research study can
begin, special care must be taken
to ensure participants' rights are
protected and that they continue to
receive appropriate medical care.
In order to protect the welfare of
research participants, the Food and

The CRL provides many services that are essential
to running a clinical research trial...
to smoothing the process
of grant submission by
preparing and reviewing
biographical sketches,
resource and environment information, letters
of collaboration, IRB
approvals, and budget
justifications. They work
closely with faculty on
research design, editing
and advising on the various sections throughout
each step of the process
and allowing more
time for the clinician
to concentrate on the
medical science of the
grant proposal.

Drug Administration requires IRB
approval for all biomedical
research involving humans. The
CRL staff has years of experience
in assisting investigators in the
preparation of a successful IRB
application. They also help investigators to prepare for periodic IRB
reviews of ongoing research,
ensuring that protocols and related
materials—informed consent
documents and investigator
brochures— are up to date and
meet or exceed the review
board standards.

,, Bringing
ideas to life
The CRL Staff

Finding the right people

•Darlene Bird, RT(R) (M), clinical
research specialist

Once a project is approved,
CRL staff identifies and screens
potential research participants.
Diligent and qualified CRL team
members interact with potential
study participants, educating them
about the goals of the study and

•Jeffrey Brown, MD, director
•Angela Campbell, RT(R) (M),
clinical research specialist
•Lora Gallagher, clinical research
coordinator
•Ellen Haenni, research secretary
•Robin Haverman, manager
•Ruth Holdener, RT(R), clinical
research coordinator
•Eileen Jacobs, RT(R) (M),
clinical research coordinator
•Shelly Meese, MHA, CRA,
assistant director
•Jill Neu, RT(R), clinical research
coordinator
•JoAnn Nevilles, research assistant
•Patty Nieters, RN, BSN, clinical
nurse coordinator
•Leslie Rickard, grant assistant
■Patty Rueweler, regulatory
coordinator

addressing any questions or concerns
they might have. This educational
process helps potential study subjects to make an informed decision
about whether to participate.
Statistical support

Statistical consultation is
encouraged in the early phases
of project development in order to
assure appropriate study design,
data collection, and data analysis.
Charles Hildebolt, DDS, PhD,
professor of radiology, and
Thomas Pilgram, PhD, instructor
in radiology, are available to
provide statistical support to the
diagnostic radiology faculty.

■Mandie Street, RT(R), clinical
research coordinator
-Kathy Taylor, clinical research
coordinator
•Jeanine Wade, RT(R), clinical
research coordinator
•Rochelle Williams, data assistant

and Jill Neu, RT(R), with Marilyn Siegel, MD, a lead
radiologist for IRAT.

Services provided by the CRL
have been particularly useful for
Washington University School of
Medicine's participation in the
National Lung Screening Trial
(NLST), sponsored by the National

CRL staff has carried out all aspects of the study.

•Linda Schimmoeller, RN, BSN, CCRC,
clinical research specialist

(Left to right) Jeanine Wade, RT(R); Lora Gallagher;

Mastering a large-scale challenge
The NLST

i

1

I

Cancer Institute (NCI). The NLST
is an ongoing multicenter study
designed to compare lung cancer
mortality rates in smokers
screened for lung cancer by chest
X ray or computed tomography. At
the Washington University site, the
CRL staff has carried out all
aspects of the study, including
patient recruitment and enrollment, preparation of images for
viewing, computerized data entry,
and tracking participant health status. Since the study's launch in
2002, nearly 3,800 participants
were recruited at the Washington
University site.

I RAT

David Gierada, MD

David Gierada, MD, associate
professor of radiology and co-principal investigator for the Washington University NLST site, finds the
CRL staff to be an invaluable asset:
"A trial of the size and complexity
of the NLST requires considerable
skill, organization, and coordination, so the performance of the
CRL has been truly impressive.
This has involved efforts of numerous study coordinators, nurses, as
well as data entry and office support staff, working in conjunction
with radiologists and designates of
the NCI overseeing the trial. In the
NLST and other clinical imaging
studies, having study coordinators
with a radiology background
ensures the technical standards of
imaging protocols are met and optimal image quality is maintained for
scientific purposes."
The NLST is now closed to
enrollment, but the CRL will continue to be involved in patient follow-up and retention until its
expected completion in 2011.

The CRL also works closely
with the Imaging Response Assessment Team (IRAT) led by Barry
Siegel, MD, professor of radiology
and of medicine and chief of
Mallinckrodt Institute's Division
of Nuclear Medicine. IRAT, also
funded by the NCI through the
Siteman Cancer Center, is a shared
resource designed to promote
collaboration between radiologists
and oncologists during early stages
of clinical trials, when imaging
could predict clinical outcome.
Marilyn Siegel, MD, professor
of radiology and of pediatrics and
the lead radiologist for conventional

"One of our greatest advantages is that members of the CRL
are intimately familiar with all
imaging modalities, including computed tomography, magnetic resonance imaging, ultrasound, and
mammography," says Robin Haverman, who directs the clinical
research staff. "Physicians conducting research involving any type
of imaging can benefit immensely
from services provided by the CRL
and can be assured their projects
are in qualified hands."
"With demanding clinical commitments, the diagnostic radiology
faculty has limited time to develop
research, so they seek resources

"One of our greatest advantages is that members of the
CRL are intimately familiar with all imaging modalities..."
imaging studies, heads a team of
six dedicated IRAT radiologists
who perform all measurements of
tumor response to the treatment
under investigation, ensuring
consistency within a study.
The CRL coordinators monitor
all incoming requests, schedule
and prepare images for review,
and track all images and results,
so the IRAT radiologist can
concentrate exclusively on
interpreting exams.

from the CRL," adds Meese. "Our
role is to do all we can to help
radiology faculty succeed. If they
succeed—then we do." EH

Expanding their focus
The CRL, although still
primarily focused on working
with radiologists, is now assisting principal investigators in
other departments with imagingrelated research. In most cases,
a recommendation is made
to include a radiology co-investigator to provide technical and
clinical support.
Patty Nieters, RN, is working with Suresh Vedanthatn, MD, the
national principal investigator for a multicenter, NIH-funded study on the
aggressive treatment of deep vein thrombosis (blood clots in the leg).
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Uterine Fibroid

Embolization
A Uterus-Sparing Alternative for
Treating Fibroids

An estimated 70 percent of all women between the ages of 35
and 60 have uterine fibroids; one in four women in the United
States has symptomatic fibroids severe enough to require treatment. Over 600,000 hysterectomies are done each year—many
of them for fibroid symptoms—at a cost of $5 billion. But there
is a cost-effective alternative to hysterectomy and its attendant
complications: uterine fibroid embolization (UFE), sometimes
called uterine artery embolization (UAE). Over 100,000 UFEs
have been performed worldwide with an enviably low complication rate. UAE has been used since the 1990s for emergency
embolization for postpartum hemorrhage or to stabilize bleeding
of a tumor prior to surgery.
by Mary Jo Blackwood, UN, MPH, CHES

At Mallinckrodt Institute of
Radiology (MIR), Michael Darcy,
MD, leads a team of interventional
radiologists who collectively
have decades of experience with
UFE. "We believe there is a large
population of women who could be
successfully treated with this procedure, but it is often overlooked
as an option due to a general lack
of awareness among the patients
and their doctors," he says. "We
strive to provide our patients with
information and education on the

procedure and other alternatives so
they can make an informed choice.
Lynn Hoese, a registered nurse on
our team, excels in working with
the patients and their families to
provide procedure-related education
and support."

"We believe there is a large population of women who
could be successfully treated with this procedure, but
it is often overlooked as an option due to a general lack
of awareness among the patients and their doctors..."
How UFE Works
The patient must fast overnight.
During the procedure—which
takes about an hour and is done
in the interventional radiology
suite—the patient receives a local
anesthetic. Then, a catheter (a thin
tube) is passed into an artery in the
groin and threaded into the uterine
arteries where tiny embolic particles—
about the size of grains of sand—
are released. Riding along with the
blood flow, these particles become
lodged in the tiny arterioles feeding
the fibroids and uterus, blocking
the blood supply. If the uterus'
blood supply is removed, it draws
on other vessels for a blood source
and totally recovers within a couple
of days. Fibroids, however, quickly
starve to death when deprived of
their blood supply, stop producing
excessive bleeding, and become
soft and spongy, taking the pressure off adjacent organs. Over time,
the fibroids shrink to 50 percent or
more in size.
Left: Selective injections into a uterine artery with
a large hypervascular fibroid
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Nassir Siddiqi, MD, assistant
professor of radiology, has been
performing UFE for more than
seven years with excellent results.
For patients concerned about
cutting off the blood supply to the
uterus, he explains that the uterus

is a resilient organ with the ability
to withstand periods of blood flow
deprivation: "During childbirth,
for example, the uterus cuts off its
own blood supply, while detaching
the placenta, to keep the woman
from bleeding to death. Nature
designed it very well."

QVMPTn
Uterine fibroid
symptoms

• Heavy, prolonged
menstrual flow
• Unusual monthly bleeding,
sometimes with clotting
• Back and leg pain
• Pelvic pressure and pain
• Bloating and constipation
caused by pressure on bowel
• Frequent urination caused
by pressure on bladder
• Enlarged abdomen.
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UTEmbolization
Uterine Fibroid

Left: Aortogram post-embolization, with no
significant perfusion of the fibroid

1TX

Regaining quality of life

F T JFTC

"When I was having such heavy cramping and bleeding from my
fibroids, I thought hysterectomy was my only option I wouldn't have
thought of UFE, but my gynecologist brought it up, showed me a pamphlet
on it, and gave me Doctor Darcy's name, explaining that the procedure is
done by an interventional radiologist,"
Karen Wehmeyer had a magnetic resonance scan prior to her appointment
with Darcy, who showed her the films and mapped the route he would use to
do the embolization. He also laid out her options, the pros and cons, so that she
knew what to expect every step of the way. Wehmeyer gave Lynn Hoese, Darcy's
nurse, high marks for her explanation of the procedure and what to expect.
"I had IV [intravenous] sedation, and I went into the operating room awake
but relaxed. The anesthesiologist, the nurse, and Doctor Darcy talked to me
throughout the procedure, which took about an hour. They explained everything they were doing and included me in the conversation. I felt like I was in
very competent hands."
Wehmeyer stayed overnight in the hospital so her pain medication could
be regulated. A pain pump was connected to an IV during the procedure and
when the cramping started, she understood how to use it and was able to get
relief from the pain. She went home the next morning, with a supply of oral
pain medications. The pills managed the pain adequately and after two days,
she didn't need them.
"I took a week off from work to give my body time to recover, but after
that, I was cleaning house and really wanted to get back to work. Two days
after the procedure, I went to my daughter's dance competition and climbed
to the top of the bleachers in the gym with no problem," she says.
Her real excitement, though, is the relief from her symptoms. "After the
procedure, I had a very scant two-day period and then didn't another one for
three months. The periods I've had since then have been extremely light. I have
recommended this procedure and Doctor Darcy's team to all of my friends.
There is really no recovery as compared to abdominal surgery, so I got my life
back quickly."

12

Says Siddiqi, "UFE has many
advantages over hysterectomy: It
is minimally invasive. The tiny nick
in the groin leaves no scar, so it's a
good cosmetic result. We use thin
catheters to access the arteries
supplying the uterus. No general
anesthesia is involved, and patients
are ambulatory in six hours or less.
They resume oral intake shortly
after the procedure and generally
stay one night in the hospital, so
we can control any pain."
"The fibroids start dying
immediately after UFE is completed. The release of chemicals
from the dying fibroids into the
systemic circulation causes some
cramping. The cramping may be
initially severe but is easily controlled by pain medicines given
intravenously in the hospital and
then oral medications for a couple
of days," Siddiqi adds. "The procedure is more cost-effective than a
hysterectomy, is need only once in
the majority of patients, and most
patients are back to work within a
week or so versus six weeks with a
hysterectomy. Most patients have
satisfactory resolution of symptoms
with this procedure."
The success rate of UFE is
impressive: 90 percent when the
predominant symptom is heavy
bleeding; 85 percent if the main
symptom is pressure and bulk. For
women who want to have children,
UFE spares the uterus. "However,
there is not enough data to claim
that fertility is not affected. There
is a small chance that UFE will
affect the ovaries because of tiny
connections between the ovaries
and uterus and blocking the arteries
that feed the ovaries. It can happen
in up to ten percent of women,
more often in patients over the age
of forty five," says Siddiqi. "If a
woman wants to become pregnant,

MALLINCKRODT INSTITUTE OF RADIOLOGY

(Left to right, clockwise): doctors Michael Darcy, Naganathan Mani, Darryl Zuckerman, Nael Saad, Nasir Siddiqi, and Jennifer Gould

she may want to consider hormonal therapy or myomectomy, an
invasive surgical procedure that
removes individual fibroids directly."
However, results of alternative
therapies are mixed: The effects of
hormonal therapy are temporary,
and symptoms usually recur after
hormonal withdrawal. There are
40,000 myomectomies done annually, but Siddiqi cautions that it's an
aggressive, invasive procedure—
and sometimes the fibroids

"The procedure is
more cost-effective
than a hysterectomy..."
removed might not be the ones
causing the symptoms. The surgery
also leaves areas of weakness and
scarring in the uterus that potentially could cause complications
during childbirth.
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Uterine Fibroid Facts ^^^^^^^^^^—
• Every 10 minutes, 12 hysterectomies are performed in the United States.
• The majority of hysterectomies performed are due to the presence of
uterine fibroids.
• 37 percent of all women undergo hysterectomy by age 60.
• African American women are 2 to 3 times more likely to have symptomatic
uterine fibroids, typically at a younger age than other women with
uterine fibroids.
• Average age range for fibroids to become symptomatic is
35 to 50 years.
• Obesity is associated with the presence of uterine fibroids.
• Recent research has shown some protective value [reduced
incidence of uterine fibroids) to the consumption of green
vegetables, fruit, and fish
• Fibroids often grow rapidly during pregnancy when hormone
levels are elevated and shrink after menopause when hormone
levels decrease.
Source: National Uterine Fibroids Foundation website: www.nuff.org/health.htm
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Uterine Fibroid

Embolization

We provide complete patient care,
including follow-up care after the
procedure in conjunction with the
referring physician."
Could a fibroid really be cancerous? Siddiqi explains that the
MIR interventional radiologists
make an extraordinary effort to
address not only this issue but to
assure that they are not dealing
with other occult cancers of the
uterus manifesting as bleeding. In

As more information is publicized about the effectiveness of UFE,
referrals continue to grow, and
now Mallinckrodt Institute has the
largest experience with UFE in
the St. Louis Metro area.
Editor's Note: To speak to a doctor or
nurse about UFE, call (314)362-2375 or
toll-free at 1-866-254-7237. EH

"...We provide complete patient care, including
follow-up care after the procedure in conjunction
with the referring physician."
Lynn Hoese, RN, provides procedure-related information to patients and their families.

Appropriateness of UFE
"Not every woman with pelvic
pain and excessive bleeding has
fibroids. MIR interventional radiologists personally evaluate the patients
during a clinic consult and obtain a
magnetic resonance scan to make
sure the fibroids are of the type and
size that could be causing symptoms,"
says Darcy, professor of radiology.
"Contrary to some misconception,
most IR [interventional radiology]
practices follow a clinical model of
patient care: obtaining a patient's
medical history; conducting a physical exam; arranging for required
labs and procedures, admissions,
and pre-certifications; and providing
extensive patient education, including a discussion of the risks, benefits,
and alternatives of the procedure.

ii

addition to the extensive history
and physical exam, patients must
have had a normal Pap smear
[Papanicolaou screening test for
cervical cancer] within the last
year. Patients above a certain age
who have irregular bleeding are
referred to their gynecologists for
an endometrial biopsy. This, together
with the magnetic resonance imaging (MRI) of the pelvis, can identify
other problems, if present. After
undergoing UFE, the patient has a
follow-up appointment after a few
weeks and at six months, when
they will have a repeat MRI to confirm all changes. All information is
shared with the referring physician
to ensure continuity of care.

rpTJi A 1\/r
The MIR Team
Michael Darcy, MD
Jennifer Gould, MD
Lynn Hoese, RN
Naganathan Mani, MD
Nael Saad, MD
Nassir Siddiqi, MD
Darryl Zuckerman, MD
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PUSHING BACK BOUNDARIES

A St. Louis MRI scanner to be used in brain research in Argentina
by Steve Kohler

H

1 i

Out with the Old—the Siemens Visions MRI
scanner was moved from the Imaging Center
on Scott Avenue.

.

The indigenous Kolla people
reside in the remote,
mountainous plains of
northwestern Argentina—
more than 1,500 kilometers
from Buenos Aires. They have no
cars, few roads and, in many
villages, only locally produced
electricity. The train that once
served the area stopped running
15 years ago. As a result, if the
Kolla develop serious illnesses,
they often go untreated. With only
six psychiatrists for the entire region
of 650,000 people, mental illnesses
are particularly underdiagnosed.
But soon, a world-class diagnostic imaging device—a magnetic
resonance imaging (MRI) scanner—
will be delivered into their midst.
Getting it there required every bit
of the collaborative spirit and
tenacious purpose that characterize
the endeavors of Mallinckrodt
Institute of Radiology (MIR) and
Washington University.
THE SEED
Three years ago,
when MIR faculty began
to contemplate the need
for a new research scanner, they wanted it to be
an addition, not a
replacement. The East
Building's existing scanner—a highly developed
and well-tuned device—
had been a "workhorse,"
according to Marcus
Marcus Raichle, MD
Raichle, MD, professor
of radiology, of neurology, and of
neurobiology. Many projects were
being conducted with it as the data
collection device.
So when space and budget
constraints eventually made it clear
that a new machine would have to
replace the old one, sending the
older scanner off for scrap seemed
inappropriate and wasteful, Raichle
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Out with the Old—the scanner begins its long journey to a hospital in Argentina.

says. Conversations soon began
about how the machine might
continue to be of service somewhere
else. No one remembers the exact
details, but during those discussions,
Yvette Sheline, MD, professor of
radiology and of psychiatry, mentioned a project being conducted in
Argentina by a colleague, Gabriel
de Erausquin, MD, PhD, associate
professor of psychiatry and of ...
neurology, that involved investigations into untreated schizophrenia.

Eventually, de Erausquin was
invited to make a presentation to
the Mallinckrodt Institute committee
about how a scanner could benefit
his research.
Thus began the saga of the first
donation of such a device by a university to a drastically underserved
region, a complex and layered
puzzle that has called upon the
talents of many people but especially Thomas Conturo, MD, PhD,
associate professor of radiology,

MALLINCKRODT INSTITUTE OF RADIOLOGY

of physics, and of biomedical
engineering. Displaying his nature
as a scientist, Conturo calls the
experience, "one big experiment."
Instead of Petri dishes and DNA
analysis, the tools in this experiment include U.S. Air Force C-17
Globemaster flights to Argentina,
carrying 14 huge crates plus the
scanner's magnet—about 36,000
pounds of equipment, including
the 23,000-pound magnet. Given all
that the MIR team learned, Conturo
is convinced that the experiment
now could be replicated.
THE DELIVERY

The size of the payload was
just one of the project's complicating factors. "It was an ambitious
undertaking," Conturo says. Getting
the magnet out of the scanner bay
was the first challenge. Lots of help
is available to install a newly purchased magnet, but the logistics
and cost of disconnecting and
removing this used one all fell
to Washington University. Then it
had to be trucked, boxed, and stored
in such a way that it could
be reassembled.

»J».

Above: Gabriel de
Erausquin, MD, PhD
Right: Thomas
Conturo, MD, PhD

Conturo
says legal
questions
surrounding
the donation—
What was the
value of the
scanner?
Who are the requirements for
duty-free entry into Argentina?—
required nine months. Then came
the move itself. Trucking it to
Miami for loading onto a container
ship was ruled out because the
cargo wouldn't fit under many
highway overpasses. Departure via
Chicago and the Great Lakes was
no better, and a route via the

In with the New—the scanner was then moved
into Bay 3 on the first floor of the Imaging Center.

They also knew that no shipboard container was big enough.
At 105 inches high (or even 95
inches if all possible parts were
removed), the scanner's magnet
would need an open-topped container,
and U.S. Homeland Security requires
sealed containers. So they proposed
air transport. But no commercial
plane flying to Argentina could haul
such cargo.

"They knew the legalities of getting
through customs anywhere..."
Mississippi River was not possible.
There was talk of giving up, Conturo and Raichle admit.
Then, a chance meeting between
Conturo and scanner transportation
specialists at the Radiological
Society of North America's annual
meeting reinvigorated the project.
"They were with the company that
moved the Rolling Stones' rockand-roll stage show to Russia,"
Conturo says. "They knew the
legalities of getting through customs
anywhere and regularly moved
huge payloads."

That left only the military. While
he was participating in a conference
in Buenos Aires, de Erausquin
learned from his collaborators that
the U.S. Air Force routinely flies
supplies to South America (known
as a channel flight). But whom to
contact? Raichle says he jokingly
suggested calling the Pentagon by
looking under "P" in the phone
book—which turned out to be
exactly what de Erausquin had
done, only to learn that the correct
people were in MIR's back yard at
Scott Air Force Base in Illinois.

In with the New—the 3 Tesla Siemens Trio (a wholebody scanner) was hoisted onto metal tracks.
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Fortuitously, the U.S. Air Force
regularly runs a huge plane full of
humanitarian supplies to South
America. And "yes," they said, the
scanner could go at no charge
under the auspices of the U.S.
Congressional Denton Amendment
that allows donors to use space
on U.S. military cargo aircraft to
transport goods and equipment to
countries in need. The Denton
Program is run by the U.S. Agency
for International Development
(USAID); after application to the
program, approval by the U.S.
State Department, and months of
coordination between USAID officers and FULTRA (the foundation
responsible for the project in
Argentina), the scanner shipment
was authorized and a transportation solution was finally in place.
That breakthrough, Conturo
says, revealed the next layer of
complications. The magnet had to
be restrained on the plane to resist
g-forces of 3.0 to 4.5g, so a structural
engineering analysis had to be
performed—which a U.S. Air
Force engineer had to approve—in
order to certify the cargo for airlift.
Because the scanner is a precision
device, chains can't simply be
slung around it. Enter Washington
University's machine shop and
facilities management. The
restraint system—consisting
of a steel frame, beams,
wooden packing, and chains
through steel rings—was
designed (and is still evolving),

in consultation
with the Air
Force, and a
structural analysis
is underway.
Arrangements
for getting
components of
the scanner from
Buenos Aires,
across the continent
using military
tank transports,
into an appropriate
location, and for
obtaining installation and operation
funding were facilitated by de
Erausquin's established contacts
with health agencies and the
military in Argentina.
THE REINCARNATION
In its new life in Salta, the
scanner will be a wellspring of
health benefits to the Kolla people
and others of their region, where
no other MRI scanner exists.
Installed in the Hospital Militar de
Salta (Hospital Bedoya), it could
perform perhaps 10 scans per day
for as many as the next five to 10
years, benefiting up to 36,000
patients who otherwise would
never have a MRI scan, Conturo

Water cabinets to be loaded into the hold.

says. Because ownership of the
scanner was transferred to a freestanding institute operated under
an agreement between two healthcare foundations, all MRI imaging
will be provided at cost to most
users and free-of-charge to the
Kolla population.
The scanner also adds an important layer to de Erausquin's research.
Until now, his investigations into
untreated chronic schizophrenia in
the region have progressed without
a sophisticated imaging component.
Scott Air Force personnel loaded the water cabinets
onto a flatbed for transport to the cargo plane.

THE UNSUNG
In addition to Raichle, Conturo, de
Erausquin. Sheline, and Gilbert Jost,
MD, director of Mallinckrodt Institute
and head of the Department of Radiology,
many people and organizations pitched
in to make the donation of the scanner
possible. Here are a few, with apologies
to those overlooked.
Washington University
• John Kreitler, machine shop
• Gary Maus, purchasing
Mission accomplished: The water cabinets are secured
in the plane's hold and are ready to be flown to
South America.

"The lack of advanced imaging has
been a limitation on the work,"
de Erausquin says. It's a "core
need" in his attempt to get a handle
on the cascade of events behind
schizophrenia.

the disease. Through diagnosis,
clinical care, and research involving
this population, it may finally be
possible, de Erausquin says, to
ascertain whether any changes in
the brain, detected by MRI imaging,
are attributable to the disorder or
to drug treatment. The research in
the Andes ultimately may resolve
long-running uncertainty and disagreement among researchers
worldwide about whether certain
observations in schizophrenia are
truly a part of the disorder or are

"It was an ambitious undertaking..."
The precise neurophysiological
images the scanner produces will
assist in separating the clinical
manifestations of schizophrenia
according to their potential
causes—genetics, damage to
particular neurons during development, and others. The comparison
of specific changes in behavior and
movement with changes in brain
physiology that the scanner makes
observable will be invaluable to
the research, he says.
Because schizophrenia among
the Kolla so frequently goes undiagnosed and untreated, the newly
diagnosed, newly treated patients
in these studies will be relatively
unaffected by powerful pharmaceutical therapy usually prescribed for
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actually attributable to the side
effects of pharmaceutical treatments.
Literally pushing back boundaries—from St. Louis to the Puna
de Atacama range of the Andes—
Mallinckrodt Institute faculty and
their many colleagues kept at this
project in the knowledge that
their beloved old scanner could be
of real benefit. With the device
expected to be operational sometime in 2009, they will get to relish
all of the ways in which that turns
out to be true, from providing an
accurate diagnosis of a single head
injury that occurred 9,000 kilometers away to possibly putting to
rest some of the most persistent
questions in brain research. EM

• Roy Van Hee, facilities management
• Marion Harris, Center for Clinical
Imaging Research at Mallinckrodt
Institute
I

Industry
• Lee Wyman, Ben-Hur Construction
St. Louis
• Grace Warner, Rock-It-Cargo
transport service
• Jonathan Wood, Siemens Medical
Solutions USA, Inc.
• David Purdy, PhD, Siemens Medical
Solutions USA, Inc.
• Siemens Argentina
• Mario Gomez, PhD, structural
engineering consultant, St. Louis
Military
• Technical Sergeant Charles Rager
and colleagues, 375 Logistics Readiness Squadron air transportation
specialists, Scott Air Force Base,
Illinois
• Ken Hundemer and Mike McAvoy,
Denton Program, Charleston Air
Force Base, South Carolina
• Eric Treadwell, Wright-Patterson
Air Force Base, Ohio
• Ejercito Argentino [the Argentinean
Army)
• Eliana Korin, U.S. Air Mobility
Command, Argentina
Foundations
• USAID Denton Program
• FULTRA Foundation, Argentina
• FUSEA, Argentina
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cargo to deliver,

you need a truck of the right size and configuration. Too
small, and the payload won't fit. Too big, and overpasses,
tight turns, and other obstacles restrict your destination.

The problem is essentially the same for researchers
exploring the delivery of imaging agents and therapeutic
radiation or pharmaceuticals using nanoparticles. It may
be counterintuitive to think of a submicroscopic particle
about the size of a single virus virion as a truck, but in
many ways, the analogy holds, according to Michael
Welch, PhD, professor of radiology, of chemistry, and of
molecular biology and pharmacology.

Small animal projection positron emission tomography (PET) image at 4 hours:
hind limb ischemia in mouse model using control-comb nanoparticle (NP), shown on
right within red circle, and avS3 targeted-comb NP, shown on left. Uptake of a^3
targeted-comb was higher in the ischemic hind limb (shown on left) as compared to
the control limb.

What are
nanoparticles?
Though they are almost incomprehensibly tiny delivery devices,
nanoparticles nonetheless are
larger than the small molecules

nanoparticles that are injected into
the bloodstream can go to destinations that microparticles cannot.
They also are not rapidly screened
out of the system by the body's filters, such as the lung and the spleen.
Nanoparticles can be manufactured from many substances—inorganic particles are often forms of
iron or gadolinium, a rare earth

"...there are adverse effects and risks to everything,
and we want to reduce them as much as possible while
we maximize the benefit."
commonly used to enhance imaging, known broadly as contrast
agents. Those small molecules can
be manufactured to have, "one,
maybe two functions—a targeting
element and something that can be
detected to make an image," Welch
says. By contrast, nanoparticles
can be "decorated with many small
molecules" that enhance their functionality. And because they are
only one-tenth to one one-hundredth the size of microparticles,

mineral with magnetic properties.
Those that Welch, associate director of oncologic imaging for Siteman Cancer Center, develops are
organically based. They originate in
the laboratory of Karen Wooley,
PhD, professor of chemistry and of
radiology, who says that her
nanoparticles are similar in composition to the Styrofoam™ in a
throw-away coffee cup, which,
believe it or not, is organically
based. Others start as polyacrylic

Crafting Organic Nanostructures with Well-defined Sizes. Shapes, Structures, and Properties:
Robust nanoscale objects for fundamental studies and applications in nanomedicine
• Cell transaction component
-permeation peptide

■X

Targeting component for cell surface
- antibody, peptide or small molecule

E

Therapeutic payload *«*
-drug,protein or gene

s
(Detection element
-radionuclide,MRI agent,
or optical chromophore

© Stealth character
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Michael Welch, PhD

acid, akin to the absorptive filling
in disposable diapers. Either way,
their organic nature provides a
measure of security against potential
toxicity, Welch says. "Once they've
done their work, they fall apart."
Cardiac disease and cancer research
Welch and Wooley have been
exploring the potential for
nanoparticles in imaging for six
years, funded by a major grant
from the Heart, Lung and Blood
Institute of the National Institutes
of Health. Mallinckrodt Institute of
Radiology at Washington University is one of only four centers in
the nation named to develop nano
agents for applications in cardiac
disease. Lately, Welch and Wooley
have been working to control the
size, shape, flexibility, and composition of the particles so they can
be tailored to do precisely the work
that the researchers want done.

Targeting component for%
3
intracellularmRNA-PNA
NA\
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Karen Wooley, PhD

By manufacturing nanoparticles with surface chemistries that
react to water at known rates, the
researchers can dictate the length
of the nanoparticles' lives. That
means, Welch says, that
the life of a radioactive tag that's
attached to a nanoparticle is able
to be controlled—functional long
enough to generate an image but
degraded and cleared from the
body quickly thereafter. By using

the available surface to attach
many such radiolabels, the image
produced is brighter than what was
possible previously, and a lower
dosage gives a better diagnostic
image. Lower dosages are desirable
because they produce fewer
adverse effects.
Also instrumental in determining the lifetime of the nanoparticles, Wooley says, is the size. Small
versions, what she calls "stealth"
particles, take longer to be
detected and don't antagonize the
body's defenses as quickly, so they
survive longer. That control is
important, Wooley says, particularly because "there are adverse
effects and risks to everything, and
we want to reduce them as much

Wooley and Welch also attach
targeting molecules to the surfaces
of the nanoparticles to steer the
complex precisely to a specified
destination. Using antibodies, peptides, and ligands (molecules that
recognize and bind to specific
receptors), they have developed an
array of clever systems for targeting particular locations. For example, certain peptides recognize and
bind to enzymes of the immune
system that are up-regulated as
part of the body's inflammatory
response. Exploiting this activity
provides the investigators with an
effective way to make images of
the inflammation that is characteristic of lung damage or acute vascular injury. "If you can see the

"If you can see the inflammation and assess its extent,
you may be able to guide therapy more successfully.55
as possible while we maximize the
benefit." Controversy exists, for
example, over the safety of gadolinium nanoparticles, with some of
the opinion that they can cause
serious injury to the liver.

I Nanoparticles get their name from the prefix
"nano," meaning one-billionth. Strictly speaking,
they should then be a billionth of a meter in diameter or long dimension.
That's 109 meters, if that helps. In fact, the group of particles classed as
"nano" ranges from five to 100 nanometers in size, Wooley says.
That's roughly the size of a virus particle, or virion, which is still not very
instructive. So Wooley offers this image: In size, a nanoparticle is to an
average human body as that human body is to the planet Earth.
Or, try this: If you have a full head of hair and, instead of being as big as they
are today, the individual hairs were the thickness of a single nanoparticle,
iu'd appear completely bald to the human eye, the strands invisible.

inflammation and assess its extent,
you may be able to guide therapy
more successfully," Welch says.
In their work on heart disease,
the researchers have devised methods for targeting blood clots and
atherosclerotic plaques, indicators
of an impending heart attack that
otherwise would be difficult to
diagnose until the event has
occurred. Welch believes nanoparticle imaging may make it possible
to determine the extent of preheart attack cardiac disease so that
clinicians can intervene before disaster strikes..
Cancer cells also express particular receptor proteins on their
surfaces and inside cells. And by
isolating the ligands that bind to
those receptors and making them a
part of the nanoparticle's exposed
cargo, Welch and Wooley can send
the little payloads to tumors. The
delivery also can include proteins
called cell permeation peptides—
proteins that drag themselves
through the cell wall, along with
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defined targets. And
work has begun on their
use in visual imaging
applications as optical
I
probes to deliver fluorescent agents—the light
from these agents can be
detected by a new generation of scanners that
will be able to "see" and
then enhance what the
eye cannot.
Nanoparticles also
hold promise as a means
mm
to transport therapeutic
agents of several types. If
they can deliver small
molecules for imaging
purposes, and there is
room on the truck, then
they also might be used
to haul pharmaceuticals
to carefully targeted disease sites. By controlling distribution
and dose, adverse effects might be
mitigated. Welch says the same
technique might be applied to delivering radiotherapy to tumor sites.
By using nanoparticles that release
their radiation only when they have
accurately reached a tumor, for
example, the need to treat cancer
by passing beams of radiation
through nearby, healthy tissue
could be reduced. And the potential
exists for using them in gene therapy to replace defective genes or
restore failing gene activity.
It's this multifunctional aspect
of nanoparticles and the precise
control that researchers can exert
over their behavior that make them
especially promising for radiologists.
Welch believes that nanoparticles
have the potential to be the next
big advance in imaging technology,
a future in which fewer and smaller
trucks will be guided precisely
down the body's highways to do
more work with reduced risks of
adverse effects. EH
max

t>
Radiolabeled nanoparticles can be studied in mice,
comparing three different particles with different
stealth properties.

•

whatever they are attached to. In
this way, nanoparticles assembled
to just the right size can be delivered through the cell wall to targets
residing within particular cells.
Most recently, Wooley also has
begun exploring the effects of the
shape of nanoparticles on their
behavior. "Our hypothesis is that
shape is critically important, especially in how nanoparticles traverse
openings in vasculature," she says.
Imaging application
Welch's enthusiasm over the
potential for nanoparticles springs
primarily from the emerging capability to adapt them to many forms
of imaging. They can be made to
carry miniscule radioactive payloads that show up on conventional
computed tomography scanners.
They also may be useful in magnetic
resonance imaging applications to
deliver contrast agents to precisely
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A grant from the Heart.Lung and Blood
Institute/National Institutes of Health
funds research for developing nano
agent applications in cardiac disease.
• Samuel Achilefu, PhD,
professor of radiology and
of biochemistry and
molecular biophysics
• Carolyn Anderson, PhD,
professor of radiology, of molecular
biology and pharmacology, and
of chemistry
• Stephen Brody, MD, associate
professor of medicine
• Robert Gropler, MD, professor
of radiology, of medicine, and of
biomedical engineering
» Michael Welch, PhD, professor
of radiology, of chemistry, and of
molecular biology and pharmacology
» Pamela Woodard, MD, associate
professor of radiology
» Karen Wooley, PhD, professor
of chemistry and of radiology
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Mallinckrodt Institute ofRadialogy (MIR) is internationally known
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for radiological expertise, compassionate patient care, state-of-theV-X-1--1- L~-I—L.^^ -L v/l/Vvl»
art technology, and innovative research. Providing physicians and
other health professionals with the latest medical information is an integral part ofMIR's dedication to education. And it was in
that spirit of sharing the latest radiology information that Nirvikar Dahiya, MD, research instructor in radiology, spearheaded
the organization of two sessions of Continuing Medical Education (CME) in India, one course in Agra, the other in Coimbatore.
The following is Dahiya's firsthand account of taking an MIR-based CME course on the road.
The idea of sharing MIR expertise with radiologists and
radiology residents in India
was conceived at a noon conference
in Scarpellino Auditorium. As I
heard the lectures given by MIR
faculty, I wished that residents in
my native India could be exposed
to this high quality of training and
education. I was actively involved
in education and training programs
in India and was involved in the
management of an ultrasound
training school for technologists
and doctors in Coimbatore.
On a CME trip to Thailand, I
travelled with Sanjeev Bhalla, MD,
associate professor of radiology,
and Christine Menias, MD, associate professor of radiology. During
the trip, I proposed to them the
idea of a CME course in India.

Their enthusiasm to participate was
the catalyst I had been waiting for.
For the course to be truly
effective, the Indian Radiology and
Imaging Association (IRIA) had to
be involved in the planning. Dr. N.
Kulasekaran, president of IRIA,
was very encouraging and supportive. After much deliberation, we
chose Agra as the CME course site.
Agra is easily accessible from Delhi
for international faculty, and it is
the home of the Taj Mahal—a
world renowned monument and a
big attraction for delegates. Dr.
Bhupendra Ahuja took on the
responsibility of all local organization on behalf of the Uttar Pradesh
state branch of IRIA. A team was
assembled to coordinate the entire
conference, and their efforts toward

the success of the initiative cannot
be overemphasized.
Bhalla, Menias, and I were the
final Mallinckrodt Institute faculty
for this maiden attempt. The success of this CME would be the basis
for an annual or a biannual event
focusing on different areas of radiology. Thus, it was imperative to
actively participate in the formations
of tis course curriculum and selection
of the faculty.
We decided to focus on "Body
Imaging" and a "Musculoskeletal
Ultrasound Workshop" for this first
course, which required multiple
late night telephone calls and teleconferences with the organizers in
India. Flexibility was critical in
multiple areas. We asked nationally
known speakers from India to

In Coimbatore, Dr.
Murugan, the CME orga

JRRENT IMAGING TREND

nizer, introduces doctor'
Dahiya, Menias, and

L

Clinical Update with Case Studies

Bhalla. Murugan, who
runs a state-of-the-art
diagnostic facility
in the region, visited
Mallinckrodt Institute
in 2007.
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Nirvikar Dahiya, MD, (at podium) speaking
at the CME course in Agra
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cover magnetic resonance imaging
and added faculty for the workshop
related to musculoskeletal ultrasound.
The CME in Agra was two days
(August 2 and 3) of intense work—
the faculty lectured to and answered
questions from more than 150 residents and junior radiologists
attending the CME. The workshop
received rave reviews. Everyone
appreciated the quality of teaching.
Positive feedback was put forth on
how to conduct an even better
CME and workshop in the future.
We did get to see the Taj Mahal
in Agra. The multiple pictures seen
in brochures and travelogues do
not do justice to the mausoleum's
Below: (Left to right) Bhalla, Menias, and Dohiyo at
the Taj Mahal in Agra—an internationally known
mausoleum built during the reign of Mughal Emperor
Shah Jahan in memory of his wife Mumtaz Mahal.

majestic appeal in real time.
After a brief stopover in
Jaipur, we proceeded to
Coimbatore, an industrial
city in South India. On
August 10, we conducted a
one-day CME course, which
focused on multidetector
CT technology and its role
in changing radiology management, for the local radiologists
and other physicians. We were
pleasantly surprised by the enthusiasm shown by the local students
and physicians.
Our basic idea for the CME
course in India was to achieve
"knowledge transfer" in a way that
would contribute to the future of
radiology on an international scale.
While international conferences
routinely achieve this goal, our
concerted effort at the CME in
India was to present the content
in a manner that resonates with
the excellence of the residency and
fellowship training programs at
Mallinckrodt Institute. To that
effect, I think we succeeded and
hope that our effort will motivate
other distinguished faculty from
Mallinckrodt Institute to participate in similar CME programs in
India in the future.
—Nirvikar Dahiya, MD

MIR faculty: CME Workshop,
Agra, India
Body Imaging: Newer Concepts, and "Handson" Workshop on Musculoskeletal Ultrasound
ABDOMINAL IMAGING

Nirvikar Dahiya, MD, "US and color Doppler
in liver transplant."
HRCT OF LUNGS
Sanjeev Bhalla, MD, "HRCT Part 1: lines,
nodules, cysts"; "HRCT Part 2: fibrosis, GGO
& mosaic."
GI IMAGING
Christine Menias, MD, "MDCT of ischemic &
GI bleeding"; "Virtual colonoscopy."
Christine Menias, MD; Sanjeev Bhalla, MD;
Nirvikar Dahiya, MD, "Interesting Mallinckrodt Cases Session."
IMAGING IN TRAUMA

Sanjeev Bhalla, MD, "Trauma of the chest—
Part 1: Great vessels and heart; Part 2: Nonvascular trauma."
Christine Menias, MD, "CT of blunt abdominal
CARDIO THORACIC IMAGING

Sanjeev Bhalla, MD, "CT of mediastinum";
"Logical approach to congenital heart disease.
Christine Menias, MD, "CT of acute vascular
emergencies"; "PET CT body applications."
MUSCULOSKELETAL ULTRASOUND

Nirvikar Dahiya, MD, "Basic anatomy and
technique of doing shoulder ultrasound."

CME Workshop,
Coimbatore, India
Topics

•Role of multislice CT in chest diseases
•Role of Cardiac CT in coronary artery disease
mtfT^

•Role of multislice CT in abdominal
disease/virtual colonoscopy
•Dynamic musculoskeletal ultrasound—
The perfect companion to MRI
'Role of MRI in clinical practice—
an overview.

In this section, the names of employees who are full-time
faculty or staff or who have an appointment in the
Department of Radiology are highlighted in boldface type.

NEW FACULTY
Catherine Appleton, MD,
instructor in radiology, Division of Diagnostic Radiology.
Xiang He, PhD, instructor
in radiology, Division of
Radiological Sciences.
Cheryl Herman, MD,
instructor in radiology, Division of Diagnostic Radiology.
Jack Jennings, MD, PhD,
instructor in radiology, Division of Diagnostic Radiology.
Geetika Khanna, MD,
assistant professor of radiology, Division of Diagnostic
Radiology.
Seung Kwon Kim, MD,
assistant professor of radiology, Division of Diagnostic
Radiology.
Robert Pallow, MD,
instructor in radiology, Division of Diagnostic Radiology.
Nasir Siddiqi, MD, assistant
professor of radiology, Division of Diagnostic Radiology.

FIRST-YEAR
FELLOWS
Tara Anthes, MD, breast
imaging clinical fellow,
received an undergraduate
degree from Brown University
and a medical degree from
the University of Washington.
She completed additional
training at Virginia Mason
Medical Center and a diagnostic radiology residency at
Mallinckrodt Institute of
Radiology.
Truitt Balart, MD, abdominal imaging clinical fellow,
received an undergraduate
degree from the University
of Georgia and a medical
degree from Louisiana State
University. He completed
additional training and a
radiology residency at
Louisiana State University
Health Sciences Center.
Samuel Chang, MD, body
magnetic resonance imaging
clinical fellow, received an
undergraduate and a medical
degree from Seoul National
University.
Patrick Cox, MD, PhD,
diagnostic neuroradiology
clinical fellow, received an
undergraduate degree from
Austin College and a medical/
doctoral degree from Baylor
University. He completed
additional training at
Methodist Hospital/Indiana
University.
Henry Dalsania, MD, interventional radiology clinical
fellow, received an undergraduate degree from Drury
College and a medical degree
from Saint Louis University.

Jennifer Demertzis, MD,
musculoskeletal radiology
clinical fellow, received an
undergraduate degree from
the University of Notre Dame
and a medical degree from
Emory University. She completed additional training at
Emory University and four
years (chief resident, 20072008) of diagnostic radiology
training at Mallinckrodt
Institute of Radiology.

Eric Hatfield, MD, body
magnetic resonance imaging
clinical fellow, received an
undergraduate degree from
the University of Notre
Dame and a medical degree
from Washington University
in St. Louis., He completed
additional training at St.
Mary's Health Center and
four years of diagnostic radiology training at Mallinckrodt Institute of Radiology.

Tejaswini Deshmukh, MD,
pediatric radiology clinical
fellow, received an undergraduate from Vivekananda
Jr. College and a medical
degree from Seth Gordhandas Sunderdas Medical College/King Edward Memorial
Hospital.

Alok Jaju, MD, pediatric
radiology clinical fellow,
received an MBBS degree
from Government Medical
College and Hospital. He
completed additional training at Government Medical
College and Hospital and at
Lokmanya Tilak Municipal
Medical College.

Alexandra Georges, MD,
musculoskeletal radiology
clinical fellow, received an
undergraduate degree from
Johns Hopkins University
and a medical degree from
the University of Missouri,
Columbia. She completed
additional training and a
radiology residency at University Hospital and Clinics.
Samuel Gibson, MD,
diagnostic neuroradiology
clinical fellow, received an
undergraduate degree from
Northwestern College and a
medical degree from the
University of Iowa. He completed additional training at
Tucson Medical Center and a
radiology residency at University Medical Center.
Catherine Glynn, MD,
breast imaging clinical fellow,
received a medical degree
from the National University
of Ireland.

Kartikeya Kantawala, MD,
abdominal imaging clinical
fellow, received an MBBS
degree and a diploma in
Medical Radio-diagnosis
from Lokmanya Tilak Municipal Medical College and a
medical degree from the
University of Seychelles. He
completed additional training
and a radiology residency at
Lokmanya Tilak Medical
College and Hospital and
one year of nuclear medicine
training at Mallinckrodt
Institute of Radiology.
Monica Kessi, MD, diagnostic neuroradiology
clinical fellow, received an
undergraduate degree from
the University of Portland
and a medical degree from
the Oregon Health and
Science University. She coi
pleted additional training a
Legacy Emanuel Hospital
and a radiology residency a
Saint Louis University.

MALLINCKRODT INSTITUTE OF RADIOLOGY

J '

F
Jonathan Kraus, MD,
musculoskeletal radiology
clinical fellow, received an
undergraduate degree from
the University of Notre
Dame and a medical degree
from Wake Forest University.
He completed additional
training at the University of
Alabama.
Alan Lobo, MD, diagnostic
neuroradiology clinical fellow, received an undergraduate degree from Texas A&M
University and a medical
degree from Louisiana State
University. He completed
additional training and a
radiology residency at Henry
Ford Hospital.
David Loy, MD, PhD,
diagnostic neuroradiology
clinical fellow, received an
undergraduate degree, a
medical degree, and a
doctoral degree from the
University of Louisville. He
completed additional training at the University of
Louisville and four years
of diagnostic radiology
training at Mallinckrodt
Institute of Radiology.
Jose Maldonado, MD, cardiothoracic imaging clinical
fellow, received an undergraduate degree from Tulane
University and a medical
degree from the University
of Puerto Rico. He completed
additional training and a
radiology residency at the
University Hospital, University of Puerto Rico.

Paolo Marciano, MD, PhD,
interventional radiology
clinical fellow, received an
undergraduate degree, a
medical degree, and a
doctoral degree from the
University of Pennsylvania.
He completed additional
training at the University
of Pennsylvania and four
years of diagnostic radiology
training at Mallinckrodt
Institute of Radiology.
Christopher Murdock,
DO, body magnetic resonance imaging clinical
fellow, received an undergraduate degree from the
University of Utah and a
medical degree from Kansas
City University of Medicine
and Biosciences. He completed additional training at
Forest Park Hospital and a
radiology residency at Saint
Louis University.
Amy Oberhelman, MD,
diagnostic neuroradiology
clinical fellow, received an
undergraduate degree from
Stanford University and a
medical degree from Washington University in St. Louis.
She completed additional
training at St. John's Mercy
Medical Center and four
years of diagnostic radiology
training at Mallinckrodt
Institute of Radiology.
Rosana Ponisio, MD, diagnostic neuroradiology clinical fellow, received a medical
degree from the National
University of La Plata.
Monika Prost, MD, breast
imaging clinical fellow,
received a medical degree
from Charles University.
She completed additional
training at the University of
Missouri, Columbia Health
Science Center.
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Steven Repka, MD, abdominal clinical fellow, received
an undergraduate degree
from Pennsylvania State University and a medical degree
from Temple University. He
completed additional training and a radiology residency
at Western Pennsylvania
Hospital.
Patricia Richmond, MD,
breast imaging clinical fellow,
received an undergraduate
degree from the University
of California, Berkeley, and
a medical degree from the
University of California, San
Francisco. She completed a
transitional year at Forest
Park Hospital and four years
of diagnostic radiology training at Mallinckrodt Institute
of Radiology.
Sara Rohr, MD, musculoskeletal radiology clinical
fellow, received an undergraduate degree from
Gustavus Adolphus College
and a medical degree from
the University of Iowa. She
completed additional training at Forest Park Hospital
and four years (chief resident,
2007-2008) of diagnostic
radiology training at
Mallinckrodt Institute of
Radiology.
Jonathan Sehy, MD, diagnostic neuroradiology clinical
fellow, received an undergraduate degree from the
University of Illinois, UrbanaChampaign, and a medical
degree from Washington
University in St. Louis. He
completed additional training
at St. Vincent Hospital and
four years of diagnostic radiology training at Mallinckrodt
Institute of Radiology.

Jennifer Sharp, MD,
abdominal imaging clinical
fellow, received an undergraduate from Washington
University in St. Louis and a
medical degree from the
University of Illinois.
Rakesh Varma, MBBS,
interventional radiology
clinical fellow, received an
undergraduate degree from
DG Ruparel College and a
medical degree from Seth
Gordhandas Sunderas Medical College/King Edward
Memorial Hospital. He completed additional training at
Seth Gordhandas Sunderas
Medical College/King
Edward Memorial Hospital
and at LTMMC & LTM
General Hospital.
Quan Vu, MD, musculoskeletal radiology clinical
fellow, received an undergraduate degree from the
University of Virginia and a
medical degree from Emory
University. He completed
additional training at Carilion Health System and four
years of diagnostic radiology
training at Mallinckrodt
Institute of Radiology.
Ramana Yedavalli, MD,
interventional radiology clinical fellow, received an
undergraduate degree from
Northwestern University and
a medical degree from the
University of Illinois. He
completed additional training at Northwestern Memorial Hospital and a residency
at the University of Illinois at
Chicago Medical Center.
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FIRST-YEAR
DIAGNOSTIC
RADIOLOGY
RESIDENTS
Jared Allen, MD, PhD,
received an undergraduate
degree from Brigham Young
University, a medical degree
from the University of California, Los Angeles, and a
doctoral degree from the
University of California, San
Diego. He completed additional
training at LDS Hospital.
Russell Allman, MD,
received an undergraduate
degree from Auburn University and a medical degree
from the University of
Alabama. He completed
additional training at Baptist
Health System.
Desi Dennis, MD, received
an undergraduate degree from
Southern Illinois University
and a medical degree from
Vanderbilt University. He
completed additional training at Saint Louis University.
Jay Desai, MD, received an
undergraduate from the University of Mississippi and a
medical degree from Emory
University. He completed
additional training at Brigham
and Women's Hospital.
Sara Dyrstad, MD, received
an undergraduate degree
from Augustana College and
a medical degree from Southern Illinois University. She
completed additional training at Southern Illinois
School of Medicine and its
affiliated hospitals.
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Amy Fowler, MD, PhD,
received an undergraduate
degree from South Dakota
State University and a medical/doctoral degree from the
University of Wisconsin. She
completed additional training at Gundersen Lutheran
Medical Center.
Michael Friedman, MD,
received an undergraduate
degree from Washington
University in St. Louis and a
medical degree from the University of Iowa. He completed additional training at
St. Luke's Hospital.
Amer Haque, MD, received
an undergraduate degree
from the University of Kentucky and a medical degree
from the University of
Louisville. He completed
additional training at West
Suburban Medical Center.
Joseph Ippolito, MD, PhD,
received an undergraduate
degree from Cornell University
and a medical/doctoral degree
from Washington University
in St. Louis. He completed
additional training at St.
John's Mercy Medical Center.
Clinton Jokerst, MD,
received an undergraduate
degree and a medical degree
from Saint Louis University.
He completed additional
training at St. John's Mercy
Medical Center.
Lauren Kim, MD, received
an undergraduate degree
from Harvard College and a
medical degree from Washington University in St.
Louis., She completed additional training at St. Mary's
Health Center.

Douglas Kitchin, MD,
received an undergraduate
degree from the University
of Notre Dame and a medical
degree from Indiana University. He completed additional
training at St. Luke's Medical
Center.
Jessica Lee, MD, received
an undergraduate degree
from Stanford University and
a medical degree from Washington University in St. Louis.
She completed additional
training at MacNeal Memorial Hospital.
Luke Linscott, MD,
received an undergraduate
degree and a medical degree
from the University of Utah.
He completed additional
training at Sacred Heart
Medical Center.
Nicholas Rhodes, MD,
received an undergraduate
degree from the University
of Wisconsin and a medical
degree from Washington
University in St. Louis. He
completed additional training
at Barnes-Jewish Hospital.
Gretchen Smith, MD,
received an undergraduate
degree and a medical degree
from the University of Washington. She completed additional training at Virginia
Mason Medical Center.
Robert Stachecki, MD,
received an undergraduate
degree from the University
of Notre Dame and a medical
degree from Georgetown
University. He completed
additional training at St.
Mary's Health Center.
Motoyo Yano, MD, PhD,
received an undergraduate
degree from Tufts University
and a medical/doctoral degree
from Rosalind Franklin
University of Medicine and
Science. She completed additional training at Advocate
Lutheran General Hospital.

FIRST-YEAR
NUCLEAR
MEDICINE
RESIDENTS
Joanna Fair, MD, PhD,
received an undergraduate
degree from Rice University,
a doctoral degree from the
University of Colorado,
and a medical degree from
Washington University in
St. Louis. She completed a
radiology residency at the
University of New Mexico.
Archana Kantawala, MD,
completed premedical
studies at Kirti M. Doongersee
College and received a medical degree from Pravara
Institute of Medical Sciences.
She completed an internship
and a residency at Seth
Gordhandas Sunderas
Medical College/King
Edward Memorial Hospital.
Marcus Kessler, MD,
completed premedical studies at and received a medical
degree from the University
of Cologne. He completed an
internship at the Clinics of
,
the City of Cologne; a diagnostic radiology residency
at Hospital Holweide; a
pediatric radiology residency
at Pediatric Hospital Amstei
darner Strasse; and a pediatric radiology clinical
fellowship at Mallinckrodt
Institute of Radiology.
Collins Liu, MD, received
undergraduate degrees froi
the University of California
Berkeley and a medical degr
from New York Medical Co
lege. He completed an
internship and a neurology
residency at the University
of Pittsburgh Medical Centi
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Jonathan Weiss, MD,
received an undergraduate
degree from Northwestern
University and a medical
degree from Indiana University. He completed an internship at St. Vincent Hospital
and a diagnostic radiology
residency at the Medical
College of Wisconsin.

GRANTS
Kevin Black, MD, associate
professor of psychiatry, of
neurology, of radiology, and
of anatomy and neurobiology,
as site principal investigator,
received a grant from
Boehringer-Ingelheim
Pharmaceuticals, Inc. for "A
randomized, double-blind,
placebo-controlled, flexible
dose study to evaluate efficacy
and safety of pramipexole IR
(0.125-0.5mg/day) versus
placebo for 6 weeks in children
and adolescents (age 6-17
inclusive) diagnosed with
Tourette's Disorder according
to DSM-IV criteria." Bradley
Schlaggar, MD, PhD, assistant professor of neurology,
of radiology, of pediatrics,
and of neurobiology, is
co-collaborator of the grant
Thomas Conturo, MD,
PhD, associate professor
of radiology, of physics, and
of biomedical engineering,
as principal investigator,
received a two-year grant in
the amount of $119,963 from
Autism Speaks to study
"Analysis of brain
microstructure in autism
using diffusion MRI." Collaborators are Erbil Akbudak,
PhD, research assistant
professor of radiology;
Charles Smith, PhD, University of Kentucky; and Nancy
Minshew, MD, and Diane
Williams, PhD, University
of Pittsburgh.
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Tamara Hershey, PhD,
assistant professor of psychiatry and of radiology,
as principal investigator,
received a $1.3 million grant
from the National Institute
of Mental Health, for
"Mapping mood in the subthalamic nucleus in PD."
Coinvestigators for the fiveyear grant are Kevin Black,
MD, associate professor of
psychiatry, of neurology, of
radiology, and of anatomy
and neurobiology; Tom
Videen, PhD, research
professor of neurology and
of radiology; and Joel Perlmutter, MD, professor of
neurology, of radiology, and
of physical therapy. Hershey
also is principal investigator
for a $1.1 million grant from
the National Institute of Diabetes and Digestive and Kidney Diseases to study
"Glycemic control, brain
structure and cognition in
youth with T1DM." Coinvestigators for the five-year
grant are Kevin Black, MD;
Neil White, MD, Department
of Pediatrics; and Joshua
Shimony, MD, PhD, assistant professor of radiology.
Linda Larson-Prior, PhD,
research associate professor
of radiology, as imaging
principal investigator,
received a $76,660 grant
from Cephalon, Inc. for a
Phase IV Clinical Trial—"A
randomized, double-blind,
placebo-controlled, functional neuroimaging study of
the effects of Armondafinil
(200 mg/day) treatment on
prefrontal cortical activation
in patients with residual
excessive sleepiness associated with obstructive sleep
apnea/hypopnea syndrome."
Principal investigator for the
one-year grant is Stephen
Duntley, MD, Department of

Neurology; coinvestigators
are Beth Ward, MD, Department of Neurology; Ravi
Aysola, MD, Department of
Medicine; G. Warmouth, MD;
Tonya Russell, MD, Department of Medicine; Amy
Bertelson, PhD, Department
of Psychology; Mehmet
Dokucu, MD, Department
of Psychiatry PhD; and Milan
Anadkat, MD, Department
of Medicine.
Robert McKinstry, MD,
PhD, associate professor of
radiology, as principal investigator of imaging core,
received a four-year grant in
the amount of $9,126 from
the Medical College of
Wisconsin, National Marrow
Donor Program® to "determine event-free survival at
one year after unrelated
donor hematopoieic stem
cell transplantation using
bone marrow or umbilical
cord blood in patients with
sickle cell disease."
Joel Perlmutter, MD,
professor of neurology, of
radiology, and of physical
therapy, as principal investigator, received a $3.2 million
grant from the National Institute of Neurological Disorders
and Stroke for "Validation of
neuroimaging biomarkers
for nigrostriatal neurons."
Coinvestigators for the fiveyear grant are Stephen
Moerlein, PhD, associate
professor of radiology and of
biological chemistry; Tom
Videen, PhD, research professor of neurology and of
radiology; Morvarid Karimi,
MD, Department of Neurology;
and Joanne Mark ham, MS,
research associate professor
of radiology.

David Reichert, PhD, assistant professor of radiology,
received a two-year grant in
the amount of $800,000 from
the Department of Energy
for "Microfluidic radiometal
labeling systems for biomolecules." Co-collaborator for
the grant is Paul Kenis, PhD,
University of Illinois,
Urbana-Champaign.
Yoram Rudy, PhD, professor of biomedical engineering,
cell biology, and physiology,
of medicine, and of pediatrics
and research professor of
radiology, as principal investigator, received a four-year
grant in the amount of $1.3
million from the National
Heart, Lung and Blood Institute, for "Inverse and forward
problems in electrocardiography."
Jeffrey Zacks, MD, associate professor of psychology
and of radiology, as principal
investigator, received a fiveyear grant in the amount of
$1.5 million from the National
Institutes of Health for
"Encoding and remembering
events across the lifespan."
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APPOINTMENTS/
ELECTIONS
Colin Derdeyn, MD, professor of radiology and of neurology and neurological
surgery, was appointed by
the American Heart Association to a two-year term on the
Research Committee and to a
two-year term as chair of the
Membership, Marketing, and
Communications Committee.
Bennett Greenspan, MD,
instructor in radiology, was
appointed to a three-year
term as a member of the
Practice Standards Committee of the American College
of Radiology, a two-year
term on the Program Planning Committee of the Association of University
Radiologists, and a one-year
term on the Membership
Committee of the Society of
Nuclear Medicine. He was
reappointed to a one-year
term on the Nuclear Medicine Program Directors
Committee of the Association of Program Directors in
Radiology and to a threeyear term on the Commission on Accreditation of
Medical Physics Educational
Programs.
Tamara Hershey, PhD,
assistant professor of psychiatry and of radiology, was
appointed to a one-year term
as secretary of the Washington University School of
Medicine Academic
Women's Network Board.
Linda Larson-Prior, PhD,
research associate professor
of radiology, was elected to
a one-year term as pre-clinical counselor of the Washington University School of
Medicine Academic
Women's Network Board.
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Robert McKinstry, MD,
PhD, associate professor of
radiology, was elected as a
representative of the Washington University School of
Medicine Faculty Practice
Plan to the Executive Committee of the Faculty Council.

HONORS/
AWARDS
Louis Gilula, MD,
professor of radiology, of
orthopaedic surgery, and of
plastic and reconstructive
surgery, served as an examiner for the Radiology
Boards, Louisville,
Kentucky, May 31-June 3.
Bennett Greenspan, MD,
instructor in radiology,
received the Academic
Council of the Society of
Nuclear Medicine's Distinguished Service Award.

LECTURES
Tammie Benzinger, MD,
PhD, assistant professor of
radiology, spoke on "Clinical
applications of diffusion tensor imaging" at the 6th MAGNETOM World Summit,
Munich, Germany, May 29June 1. She presented
"Advanced neuromagnetic
resonance imaging: 3 Tesla
in clinical practice" to the
Central Illinois Radiological
Society, Peoria, August 8.
Kevin Black, MD, associate
professor of psychiatry, of
neurology, of radiology, and
of anatomy and neurobiology, presented "Diagnosis
and treatment of Tourette
syndrome, 2008" at Neurology Grand Rounds,
Louisiana State University
Health Science Center,

Shreveport, June 13. He
spoke on "Quantitative pharmacodynamic imaging by a
novel method" at the Organization for Human Brain Mapping 2008, Melbourne,
Australia, June 15-19.Colin Derdeyn, MD, professor of radiology, of neurology, and of neurological
surgery, spoke on "EC/IC
Bypass/COSS Trial Update"
at the Society for Neurolnterventional Surgery Annual
Practicum, New Orleans,
Louisiana, June 6. He presented "Carotid artery stenosis: Is there a future for
neurosurgery in the treatment of disease?" at the
Robert L. Grubb Jr., M.D.
Research Symposium,
St. Louis, Missouri, June 7.
He spoke on "Acute stroke
intervention" at the 21st
Annual John H. Kendig Lecture, St. John's Mercy Hospital, St. Louis, Missouri, July 16.
Louis Gilula, MD, professor
of radiology, of orthopaedic
surgery, and of plastic and
reconstructive surgery, as
visiting professor, presented
"Radiology Board review" at
the Oregon Health and Science University, Portland,
June 23.
Tamara'Hershey, PhD,
assistant professor of psychiatry and of radiology, spoke
on "Glycemic extremes and
the developing human brain"
at the Center for Neurobehavioral Development,
University of Minnesota,
Minneapolis, August 5.
Rebecca Hulett-Bowling,
MD, assistant professor of
radiology, presented "Interesting cases and unusual
pediatric tumors" at the
Pacific Coast Pediatric Radiology Association Annual
Meeting, Napa, California,
July 29-August 3.

Linda Larson-Prior, PhD,
research associate professor
of radiology, spoke on "Neuroimaging of human sleep" at
the Sleep Research Society
13th Annual Trainee Symposium, Baltimore, Maryland,
June 8. She presented "Phase
synchrony analysis of network dynamics during task
performance links EEG and
BOLD" at the Organization
for Human Brain Mapping
Annual Meeting, Melbourne,
Australia, June 15-19.
Mark Mintun, MD, professor of radiology, presented
"FDG & amyloid PET: What
information do these provide?" at The Alzheimer's
Disease Summit, sponsored
by Mount Sinai School of
Medicine and MBL Communications, Washington, DC,
May 3. He spoke on "Metabolic domains and neuronal
activation" at the Gordon
Research Conference on
Brain Energy Metabolism and
Blood Flow, Andover, New
Hampshire, August 17-22.
Joel Perlmutter, MD,
professor of neurology, of
radiology, and of physical
therapy, presented "Mentoring the mentors" and chaired
the Biomarkers for PD Progression session at the
Parkinson Study Group
Annual Meeting, San Diego,
California, May 8
James Quirk, PhD,
research instructor in radio
ogy, presented "Optimal
sample parameter estimate
from phased array coil dat;
utilizing joint Bayesian
analysis" at the 16"' Scientil
Meeting of the Internationa
Society for Magnetic Resonance in Medicine, Torontc
Ontario, May 3-9. He spoke
on "Models and application
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of in vivo lung morphometry
with hyperpolarized 3He
MRI in a mild COPD population" at the 9"' International
Bologna Conference on
Magnetic Resonance in
Porous Media, Cambridge,
Massachusetts, July 13-17.
Yoram Rudy, PhD, professor of biomedical engineering,
cell biology, and physiology,
of medicine, and of pediatrics and research professor
• of radiology, spoke on "The
molecular basis for the clinical electrocardiogram—
electrocardiographic imaging
(ECGI): solving the electrographic inverse problem"
and "Why do T-waves
change?—Fundamental
basis of the T-wave" at Heart
Rhythm Society, 29th Annual
Scientific Sessions, San
Francisco, California, May
16. He presented "Computational biology and noninvasive
imaging of cardiac arrhythmia," for the Department of
Biomedical Engineering's
Professor Samuel Sideman
In Memoriam Lecture, and
"Noninvasive electrocardiographic imaging (ECGI) of
cardiac electrophysiology
and arrhythmia" for the
Cardiovascular Science
Grand Rounds, Israel Institute of Technology School
of Medicine, Haifa. He
spoke on "Noninvasive ECG
imaging" at the World
Congress in Cardiac Electrophysiology and Cardiac
Techniques, Nice, France,
June 19.
Yvette Sheline, MD,
professor of psychiatry, of
radiology, and of neurology,
presented "Support for the
vascular depression hypothesis: neuropsychological and
neuroimaging findings from
a prospective treatment trial
in LLD" at the American Psychiatric Association Annual
Meeting, Washington, DC,
May 3-8.
FOCAL SPOT, SUMMER/FALL 2008
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Nasir Siddiqi, MD, assistant professor of radiology,
spoke on "Arterial hepatic
brachytherapy: VIR perspective" at the New England
Chapter of the Association
of Physicists in Medicine
Annual Meeting, Norwood,
Massachusetts, June 18.
Marilyn Siegel, MD,
professor of radiology and
of pediatrics, spoke on
"Pediatric body MRI:
advances and applications"
at the 1st Educational Activity
of the Pediatric MRI Center
in Puerto Rico & Latin America, San Juan, May 19. She
spoke on "Cardiac CT in the
pediatric patient: radiation
considerations" at the 3rd
Annual Scientific Meeting of
the Society of Cardiovascular Computed Tomography,
Orlando, Florida, July 18.
She presented "MDCT of
adult congenital heart
disease and MDCT of adult
thoracic vascular anomalies"
at the Summer Practicum of
the Society of Computed
Body Tomography and Magnetic Resonance Imaging,
Charleston, South Carolina,
August 10 and 11.
Jeffrey Zacks, MD, associate professor of psychology
and of radiology, presented
"Event segmentation and
memory" at the Eightieth
Annual Meeting of the
Midwestern Psychological
Association, Chicago, Illinois, May 1-3. He spoke on
"Perceptual segmentation of
the behavior stream and the
hierarchical organization of
life events" at the SPARK
Workshop on Habit and
Routine, London, England,
May 29 and 30.

SYMPOSIA
In this section ofFYI, only
those faculty and staff who
have Department of Radiology appointments are listed.

SOCIETY OF NUCLEAR
MEDICINE
55th Annual Meeting
New Orleans, Louisiana
June 14-18, 2008
Carolyn Anderson, PhD,
"The importance of chelator
for radiometal-based radiopharmaceuticals in PET
imaging"; "What is molecular
imaging?"
Bennett Greenspan, MD,
"Radiotherapy response
evaluation: When is the optimal time for PET imaging?";
"Ethics in research—responsibilities of the investigator."
Robert Gropler, MD,
"Where is cardiovascular
molecular imaging going and
when are we going to get
there?"
Aviv Hagooly; Raffaella
Rossin; Monica Shokeen;
Carolyn Anderson, PhD;
Michael Welch, PhD, "Evaluation of a RGD-dendrimer
labeled with 7liBr in hindlimb
ischemia mouse model."
Zulfia Kisrieva-Ware, MD,
PhD; Terry Sharp; Carmen
Dence, MS; Andrew Coggan; Robert Gropler, MD;
Pilar Herrero, MS, "Assessment of myocardial triglyceride turnover with PET and
l-"C-palmitate."
Hyeran Lee, PhD; Delphine Chen, MD; Michael
Welch, PhD; Robert Mach,
PhD, "Fluorine-18 labeled
PPARy antagonists for PET
imaging studies."

Yongjian Liu; Aviv
Hagooly; Raffaella Rossin;
Jinbin Xu; Karen Wooley,
PhD; Michael Welch, PhD,
"In vivo evaluation of 64Cu
labeled PEGylated shell
crosslinked nanoparticles
(SCKs) as candidates for
imaging and drug delivery."
Jonathan McConathy,
MD, PhD; Dong Zhou,
PhD; Lynne Jones; Elizabeth Griffin; Robert
Mach, PhD, "Click synthesis
and murine biodistribution
of the radiolabeled amino
acid [18F]AFETP."
Mark Mintun, MD, "Emerging CSF and blood biomarkers
for AD and their likely impact
on the role of imaging."
Joel Perlmutter, MD,
"DAT imaging does not provide unique and clinically
useful information."
Raffaella Rossin; Aviv
Hagooly; Michael Welch,
PhD, "Characterization of
w
CU-labeled AMG 655 as a
PET tracer for imaging
Death Receptor 5 (DR5) in
tumor."
Henry Royal, MD, "Leadership success in academic
nuclear medicine"; "ABNM
perspective on MOC."
Kooresh Shoghi, PhD;
Robert Gropler, MD;
Terry Sharp; Pilar Herrero, MS; Nicole Fettig;
Michael Welch, PhD,
"Assessing the efficacy of
anti-diabetic therapies on
myocardial glucose utilization in an animal model of
type 2 diabetes (T2D) with
PET."
Yi Su; Kooresh Shoghi,
PhD, "Spatial constrained
voxel-based kinetic analysis
of small animal dynamic
PET images with wavelet
denoising."
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SYMPOSIA
Continued from page 31
Yuan-Chuan Tai, PhD;
Heyu Wu; Tae Song;
Joseph O'Sullivan, PhD;
Sergey Komarov, "A highresolution head insert device
for a clinical PET/CT scanner."
Zhude Tu, PhD; Robert
Mach, PhD, "Evaluation of
the putative dopamine D3
PET tracer ["C]WC-10 in
non-human primates."
Zhude Tu, PhD; Jinbin Xu;
Lynne Jones; Shihong Li;
Robert Mach, PhD,
"Radiosynthesis and in vivo
evaluation of ["CJpapaverine
as PDE10A PET tracer."
Jerold Wallls, MD, "IHE:
What is it and what is new?"
Michael Welch, PhD,
"Imaging tumor hypoxia with
Cu-ATSM PET."
Dong Zhou, PhD; Hyeran
Lee, PhD; Justin Rothfuss;
Delphine Chen, MD: Michael
Welch, PhD; Robert Mach,
PhD, "Synthesis, ,3F radiolabelling and in vivo biodistribution of 6-(2-fluoropropyl>
4-methylpyridin-2-amine as a
potential PET tracer."

AMERICAN CHEMICAL
SOCIETY
236th National Meeting and
Exposition
Philadelphia, Pennsylvania
August 17-21, 2008
Samuel Achilefu, PhD;
Mikhail Berezin, PhD;
Walter Alters, DVM, PhD;
Hyeran Lee, PhD; Mingfeng
Bai, PhD; Sharon Bloch,
PhD; Zongren Zhang, PhD;
Yunpeng Ye, PhD; Ralph
Nothdurft, MS; Joseph
Culver, PhD, "Fluorescence
lifetime imaging of tumors
using near infrared fluorescent molecular probes."
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Samuel Achilefu, PhD;
Yunpeng Ye, PhD; Zongren
Zhang, PhD; Hyeran Lee,
PhD; Jinda Fan, PhD; Kexian Liang; Mikhail Berezin,
PhD; Philip Cheney; Barry
Edwards, PhD, "Chemical
and biochemical contrast
strategies for optical imaging
of molecular processes in vivo."
Carolyn Anderson, PhD,
"Career in molecular imaging
research began with the 1984
Summer School in Nuclear
Chemistry."
Carolyn Anderson, PhD;
Michael Welch, PhD, "Graduate and undergraduate training in imaging sciences at
Washington University."
Ashley Fiamengo; Yungpeng Ye, PhD; Samuel
Achilefu, PhD; Carolyn
Anderson, PhD, "Binding
affinity and cellular internalization of avfi3 targeting ligands for molecular imaging
of cancer and cardiovascular
disease."
Raffaella Rossin; Michael
Welch, PhD; Karen Wooley, PhD, "Cell uptake and
the dependency on surface
moieties of differentlyshaped nanoparticles."
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ALUMNI NEWS
Yvonne Taylor, PhD, a former assistant professor in
radiology, received Colgate
University's Alumni Corporation Humanitarian Award for
her efforts to help improve
education and living conditions in the African country
of Kenya. Taylor joined the
faculty of the Division of
Radiation Oncology's Cancer
Biology lab in 1986 and left
in 1995 for a two-year stint
as a science teacher in the
Peace Corps. And she
quickly fell in love with the
Akamba people, who call her
Mwende (or Loved One).
She is the founder and CEO
of One Heart with Africa
Inc—an outgrowth of her
dream to provide the
Akamba with a clean and
adequate resource for water
(by spearheading the construction of 17 communitybuilt, subsurface dams and
water tanks along the Syuuni
River) and to provide job

Above, Left: Taylor (in white hat) is
shown with the children of Kyamathenge Primary School, where she is the
administrator and principal and "chief
cook and bottle washer."
Above, Right: Taylor (right) and her
adopted daughter Kanini Mutie, a
Kenyan orphan who is now a student
at the University of Nairobi.

training for the Akamba
children who cannot go to
college (by offering compui
training and establishing
a technical institute that
offers tailoring, dressmakii
carpentry, and masonry
classes). One Heart with
Africa (online at http://on(
heartwithafrica.org) also
provides student sponsorships and promotes cultur;
exchange.
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FELLOWS AND RESIDENTS FOR 2008-2009
Doctors Jeffrey Lin; Jonathan Sehy; Travis Hillen; Jonathan Baker; Jennifer Gould, diagnostic
radiology residency program director; Gilbert Jost, director, Mallinckrodt Institute; Sara Rohr, diagnostic radiology chief
resident; Meghan Lubner, diagnostic radiology chief resident; Jennifer Demertzis, diagnostic radiology chief resident;
Robert McKinstry, research residency program director; Sanjiv Bajaj; Paul Holcombe; Alexander Ho.
Doctors Cylen Javidan-Nejad, cardiothoracic imaging fellowship program director; Amy Oberhelman;
Rex Parker; Carlos lima; Constantine Raptis; Tabassum Ahmed; Gilbert Cheung; Vincent Mellnick; Kevin Johnson;
Calvin Barnes; Celine Buckley; Nicole Bolton; Robin Yang; Danielle Weems; Stanley Chan; Marcus Kessler; Michelle MillerThomas; Caitlin Lopez; Salil Patel; Susan Holley; Joseph Mettenberg; Patricia Richmond; Jennifer Salcman; Kristy Wolske;
Norna Ludeman; Heather Tauschek; Jakob Schutz.
Doctors Yasha Kadkhodayan; Carl Aschkenasi; Edward Hwang; Joseph Azok; Kelsey Morgan; Sushil
Sonavane; Paul Frohnert; Alok Jaju; Prakash Masand; John Burkett; William Grande; Travis Henry; Lance Reinsmith;
Kyle Shipley; Robert Cargile; Brandon Liu; Aaron Hendon; Omar Agosto; Ariel Kruger; Quan Vu; Yihua Zhou; Martin Reis;
Thomas Watson; Ferenc Czeyda-Pommersheim; Srini Peddi; Alexander Sevrukov; Benjamin Pettus; Paolo Marciano;
Jonathan McConathy; Vilaas Shetty.
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